Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Nitiss

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Nature Reviews. Cancer|April 21, 2009
DNA topoisomerase II and its growing repertoire of biological functionsJohn L Nitiss
Nature Reviews. Cancer|April 21, 2009
Targeting DNA topoisomerase II in cancer chemotherapyJohn L Nitiss
Current Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damageJohn L Nitiss
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
A copper connection to the uptake of platinum anticancer drugsJohn L Nitiss
Eukaryotic Cell|February 12, 2004
DNA repair functions that control sensitivity to topoisomerase-targeting drugsMobeen Malik, John L Nitiss
Idrugs : the Investigational Drugs Journal|June 24, 2005
Gimatecan (sigma-tau industrie farmaceutiche riunite/novartis)John L Nitiss, Karin C Nitiss
Cancer Investigation|July 4, 2002
DNA topoisomerase II as a target for cancer chemotherapyJerrylaine V Walker, John L Nitiss
Plos Genetics|March 19, 2013
Tdp2: a means to fixing the endsJohn L Nitiss, Karin C Nitiss
The Journal of Biological Chemistry|August 30, 2008
Isolation and characterization of mAMSA-hypersensitive mutants. Cytotoxicity of Top2 covalent complexes containing DNA single strand breaksAnna T Rogojina, John L Nitiss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
Twisting and ironing: doxorubicin cardiotoxicity by mitochondrial DNA damageKarin C Nitiss, John L Nitiss
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Nature Reviews. Cancer|April 21, 2009
DNA topoisomerase II and its growing repertoire of biological functionsJohn L Nitiss
Nature Reviews. Cancer|April 21, 2009
Targeting DNA topoisomerase II in cancer chemotherapyJohn L Nitiss
Current Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damageJohn L Nitiss
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
A copper connection to the uptake of platinum anticancer drugsJohn L Nitiss
Eukaryotic Cell|February 12, 2004
DNA repair functions that control sensitivity to topoisomerase-targeting drugsMobeen Malik, John L Nitiss
Idrugs : the Investigational Drugs Journal|June 24, 2005
Gimatecan (sigma-tau industrie farmaceutiche riunite/novartis)John L Nitiss, Karin C Nitiss
Cancer Investigation|July 4, 2002
DNA topoisomerase II as a target for cancer chemotherapyJerrylaine V Walker, John L Nitiss
Plos Genetics|March 19, 2013
Tdp2: a means to fixing the endsJohn L Nitiss, Karin C Nitiss
The Journal of Biological Chemistry|August 30, 2008
Isolation and characterization of mAMSA-hypersensitive mutants. Cytotoxicity of Top2 covalent complexes containing DNA single strand breaksAnna T Rogojina, John L Nitiss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
Twisting and ironing: doxorubicin cardiotoxicity by mitochondrial DNA damageKarin C Nitiss, John L Nitiss
Pageof 7